Evidence map›Paper›PMID 35213382›Full record

ArticleJournal of Alzheimer's disease : JAD2022

Serum Levels of α-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function.

Payel Kundu, Benjamin Zimmerman, Joseph F Quinn, Jeffrey Kaye, Nora Mattek, Shawn K Westaway, Jacob Raber

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Impact ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Serum alpha klotho levels in Parkinson's Disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  10. Article
  11. Frontiers in aging neuroscience · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Payel KunduDepartment of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, USA.
Benjamin ZimmermanDepartment of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, USA.
Joseph F QuinnDepartment of Neurology, Oregon Health and Science University, Portland, OR, USA.
Jeffrey KayeDepartment of Neurology, Oregon Health and Science University, Portland, OR, USA.
Nora MattekDepartment of Neurology, Oregon Health and Science University, Portland, OR, USA.
Shawn K WestawayDepartment of Neurology, Oregon Health and Science University, Portland, OR, USA.
Jacob RaberDepartment of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, USA.
Oregon Health & Science University · USOregon National Primate Research Center · USUniversity of Illinois Urbana-Champaign · US

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Zachary Beattie · 2020 to 2026
$28.6M
Outreach, Recruitment and Education CoreP30AG008017 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KAYE, JEFFREY A · 1990 to 2019
$27.7M
Neuroscience of Aging, Neurodegeneration and Alzheimer’s DiseaseT32AG055378 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI JACOB RABER, HENRYK F URBANSKI · 2018 to 2026
$4.3M
Effects of apoE Isoform, Sex and Diet on Insulin Regulation in BrainRF1AG059088 · NIA · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI BANKS, WILLIAM A, RABER, JACOB · 2018 to 2020
$2.5M
Neuronal activity modulation and age-related neurodegenerationR21AG065914 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI DANA, HOD MICHAEL, RABER, JACOB · 2020 to 2020
$695k
NCATS NIH HHS UL1 TR002369NIA NIH HHS P30 AG008017NIA NIH HHS P30 AG066518NIA NIH HHS R21 AG065914NIA NIH HHS RF1 AG059088NIA NIH HHS T32 AG055378
6 · The paper itself

Abstract

backgroundα-klotho might play a role in neurodegenerative diseases.

objectiveTo determine levels of α-klotho and apoE in serum and cerebrospinal fluid (CSF) samples and their relationship with the Mini-Mental State Examination (MMSE) and Clinical Dementia Rating (CDR).

methodsAll subjects were between age 39 to 83+ (n = 94). CDR and MMSE were administered to all participants. CSF was collected in the early afternoon by lumbar puncture.

resultsSerum and CSF levels of α-klotho are positively correlated and both predict scores on the MMSE and CDR, regardless of sex or apoE4 status.

conclusionOur results demonstrate that α-klotho may be an important biomarker of cognitive health and neurodegeneration, and that relatively non-invasive sampling of α-klotho from serum is likely highly reflective of CSF levels.

Indexed as

Alzheimer DiseaseCognitive DysfunctionKlotho ProteinsAgedAged, 80 and overApolipoprotein E4BiomarkersCognitionHumansMental Status and Dementia TestsApolipoprotein E4BiomarkersKlotho ProteinsKL protein, humanapoEcerebrospinal fluidClinical Dementia RatingMini-Mental State Examinationserumα-klotho

Identifiers

PMID35213382
PMCPMC9108571
OpenAlexW4213203638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.